1 year ago
43
Move seen as a key strategy to control the US overdose crisis, which has been linked to more than 100,000 deaths a year
The US Food and Drug Administration on Wednesday approved selling naloxone without a prescription, setting the overdose-reversing drug on course to become the first opioid treatment drug to be sold over counters in the US.
It is a move some advocates have long sought as a way to improve access to a life-saving drug, though the exact impact will not be clear immediately.
Continue reading...